홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

N-[5-amino-2-[2-(dimethylamino)ethyl-methylamino]phenyl]acetamide → Acetamide, N-[5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]phenyl]-

HRID 615
노트
인쇄 미리보기

반응식

HRID 615 반응식
CC(=O)Nc1cc(N)ccc1N(C)CCN(C)C.N#Cc1cnn2c(NC3CC3)cc(Cl)nc12>C1COCCO1.CC(C)c1cc(C(C)C)c(-c2ccccc2P(C(C)(C)C)C(C)(C)C)c(C(C)C)c1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].[Pd]>CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN(C)C
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 89825517N-[5-amino-2-[2-(dimethylamino)ethyl-methylamino]phenyl]acetamideHCID 898271735-Chloro-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile

생성물 1

HCID 76321032Acetamide, N-[5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]phenyl]-수율 15.62%

시약·촉매·용매 4

HCID 10796Cesium carbonate시약
HCID 9811564
Bis(dibenzylideneacetone)palladium
촉매
HCID 11618717Di-tert-butyl(2',4',6'-tris(propan-2-yl)-(1,1'-biphenyl)-2-yl)phosphane촉매
HCID 312751,4-Dioxane용매

반응 조건

온도
150 °C

실험 절차

Two reactions setup, each 600 mg scale. A 20 mL microwave reactor vial was charged with 5-chloro-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile (1.2 g, 5.14 mmol), N-(5-amino-2-((2-(dimethylamino)ethyl)(methyl)amino)phenyl)acetamide (1.414 g, 5.65 mmol), 2-Di-t-butylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl (0.218 g, 0.51 mmol), Pd2dba3 (0.235 g, 0.26 mmol) and CS2CO3 (5.02 g, 15.41 mmol). The vessel was fitted with a septum and gas inlet and dioxane (20 mL) was added via syringe. The resulting suspension was stirred for 5 min under nitrogen. The septum and gas inlet was quickly replaced with a microwave vial cap and the mixture was heated at 150 degrees under microwave irradiation for 1h. Two reactions combined and filtered through celite. The filtrate concentrated and submitted for purification (report attached). **Received a 3 different set up fractions:** First set up fractions (EN02868-04-1), LC-MS looks clean but 1H NMR shows acetate peak, couldn't getrid of it even longer time on lyohillizer. Second setup fractions combined, lyophllized, purified by ISCO column (0 - 20% MeOH-CH2Cl2 \+ 0.05% TEA). The obtained compound is a gum. It was triturated with 2 ml of EtOAc, formed a nice solid, it was filtered, washed with Et2O and dried to give 230 mg of white solid. 1H NMR showed slight shift of couple of peaks, it may be due to the protonation. 63 mg of this compound registered and submitted (EN02868-04-2). Third setup fractions showed no required product peaks, was discarded. EN02868-04-1, the remaining material after submission (EN02868-04-2), the filtrate of EN02868-04-2 combined, concentrated, treated with 3 g of MP- carbonate in THF (30 ml). After 1 h stirring, it was filtered washed with THF, concentrated, triturated with CH3CN, filtered and dried to give white color solid (EN02868-04-3). Conclusion: Product isolated

출처 및 근거

ORD 기록
ord-5410161a80384996abaacdd18920aec7
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트